Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

777 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switching to systemic therapy after locoregional treatment failure: Definition and best timing.
Ogasawara S, Ooka Y, Koroki K, Maruta S, Kanzaki H, Kanayama K, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Kato N. Ogasawara S, et al. Among authors: kanzaki h. Clin Mol Hepatol. 2020 Apr;26(2):155-162. doi: 10.3350/cmh.2019.0021n. Epub 2020 Jan 15. Clin Mol Hepatol. 2020. PMID: 31937081 Free PMC article. Review.
Changes in therapeutic options for hepatocellular carcinoma in Asia.
Ogasawara S, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Nakagawa R, Nakamoto S, Muroyama R, Chiba T, Kato N. Ogasawara S, et al. Among authors: kanzaki h. Liver Int. 2022 Aug;42(9):2055-2066. doi: 10.1111/liv.15101. Epub 2021 Nov 29. Liver Int. 2022. PMID: 34780081 Review.
Exploring microsatellite instability in patients with advanced hepatocellular carcinoma and its tumor microenvironment.
Mukai S, Kanzaki H, Ogasawara S, Ishino T, Ogawa K, Nakagawa M, Fujiwara K, Unozawa H, Iwanaga T, Sakuma T, Fujita N, Koroki K, Kobayashi K, Kanogawa N, Kiyono S, Nakamura M, Kondo T, Saito T, Nakagawa R, Suzuki E, Ooka Y, Muroyama R, Nakamoto S, Tawada A, Chiba T, Arai M, Kato J, Shiina M, Ota M, Ikeda JI, Takiguchi Y, Ohtsuka M, Kato N. Mukai S, et al. Among authors: kanzaki h. JGH Open. 2021 Oct 1;5(11):1266-1274. doi: 10.1002/jgh3.12660. eCollection 2021 Nov. JGH Open. 2021. PMID: 34816012 Free PMC article.
Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.
Kondo T, Koroki K, Kanzaki H, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Ogasawara S, Ooka Y, Nakamoto S, Chiba T, Arai M, Kato J, Kuboki S, Ohtsuka M, Kato N. Kondo T, et al. Among authors: kanzaki h. PLoS One. 2022 Jan 27;17(1):e0261619. doi: 10.1371/journal.pone.0261619. eCollection 2022. PLoS One. 2022. PMID: 35085277 Free PMC article.
Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis.
Ozaki T, Yumita S, Ogasawara S, Fujiya M, Tsuchiya T, Yoshino R, Sawada M, Akatsuka T, Izai R, Miwa C, Yonemoto T, Fujimoto K, Unozawa H, Fujiwara K, Kojima R, Kanzaki H, Koroki K, Inoue M, Kobayashi K, Nakamura M, Kiyono S, Kanogawa N, Kondo T, Nakagawa R, Nakamoto S, Kato N. Ozaki T, et al. Among authors: kanzaki h. Hepatol Res. 2024 Jun 29. doi: 10.1111/hepr.14088. Online ahead of print. Hepatol Res. 2024. PMID: 38943555
Analyses of Intermediate-Stage Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization prior to Designing Clinical Trials.
Koroki K, Ogasawara S, Ooka Y, Kanzaki H, Kanayama K, Maruta S, Maeda T, Yokoyama M, Wakamatsu T, Inoue M, Kobayashi K, Kiyono S, Nakamura M, Kanogawa N, Saito T, Kondo T, Suzuki E, Nakamoto S, Yasui S, Tawada A, Chiba T, Arai M, Kanda T, Maruyama H, Kato J, Kuboki S, Ohtsuka M, Miyazaki M, Yokosuka O, Kato N. Koroki K, et al. Among authors: kanzaki h. Liver Cancer. 2020 Sep;9(5):596-612. doi: 10.1159/000508809. Epub 2020 Jul 22. Liver Cancer. 2020. PMID: 33083283 Free PMC article.
777 results